Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Immune Checkpoint Inhibitors Market Surges to USD 168.76 Billion by 2030, Propelled by 15.99% CAGR - Verified Market Reports®
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): PR Newswire
- Source:
PR Newswire US. 09/25/2024.
- Additional Information
- Alternate Title:
VERIFIEDMARKETREPORTS
- Subject Terms:
- Abstract:
The immune checkpoint inhibitors market is primarily driven by the increasing prevalence of cancer, rising investment in cancer research, and the growing adoption of targeted therapies. Advances in biotechnology and the development of novel therapies have further fueled market growth, while heightened awareness among healthcare professionals and patients about immunotherapy benefits contributes to demand. Conversely, market restraints include the high cost of treatment, potential adverse effects associated with immune checkpoint inhibitors, and stringent regulatory approvals that can delay product availability. Additionally, the presence of alternative cancer treatments and the variability in patient response can pose challenges to market expansion. [ABSTRACT FROM PUBLISHER]
No Comments.